Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
New
Increased
Maintained
Reduced
Closed
Funds Holding
4,349
Funds Holding Change
+3
Funds Holding Growth
+0.1%
Value
$1.39T
Holding in Top 10
966
Top 10 Change
-21
Top 10 Growth
-2%
Value Growth
-2%
New
146
Increased
2,186
Reduced
1,746
Closed
86
Capital Inflow
$50B
Capital Outflow
$27.1B
Net Capital Flow
+$22.9B
Capital Flow Change
+$5.91B
Calls
$22.4B
Puts
$20.1B
Net Calls
+$2.22B
Put/Call Ratio
0.9